Join
Live feed
·
INSIDERFilingvia Quantisnow
Compass Therapeutics Inc. logo

CHIEF EXECUTIVE OFFICER Schuetz Thomas J. covered exercise/tax liability with 44,025 shares, decreasing direct ownership by 0.68% to 6,436,800 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CMPX· Compass Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CMPX (Compass Therapeutics Inc.) and more on Quantisnow.